SC 13G/A: APPLIED DNA SCIENCES INC

AI Summary

SC 13G/A filing by APPLIED DNA SCIENCES INC.

Risk Assessment

Risk Level: low

Filing Documents

• eh240556095_13ga1-adna.htm (SC 13G/A) — 39KB
• 0000950142-24-002757.txt ( ) — 41KB

From the Filing

SC 13G/A 1 eh240556095_13ga1-adna.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Applied DNA Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 03815U201 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 03815U201 SCHEDULE 13G Page 2 of 6 1 NAME OF REPORTING PERSON Bruce Grossman 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER Less than 1% 6 SHARED VOTING POWER Less than 1% 7 SOLE DISPOSITIVE POWER Less than 1% 8 SHARED DISPOSITIVE POWER Less than 1% 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON Less than 1% 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) Less than 1% 12 TYPE OF REPORTING PERSON IN CUSIP No. 03815U201 SCHEDULE 13G Page 3 of 6 Item 1. (a) Name of Issuer Applied DNA Sciences, Inc. (b) Address of Issuer’s Principal Executive Offices 50 Health Sciences Drive Stony Brook, New York 11790 Item 2. (a) Name of Person Filing Bruce Grossman (the “Reporting Person”) (b) Address of Principal Business Office or, if none, Residence c / o Dillon Hill Capital LLC 200 Business Park Drive, Suite 306 Armonk, NY 10504 (c) Citizenship USA (d) Title of Class of Securities Common Stock (e) CUSIP Number See cover page Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [__] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o) (b) [__] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c) (c) [__] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c) (d) [__] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) (e) [__] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E) (f) [__] An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F); (g) [__] A Parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); (h) [__] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) [__] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) [__] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). CUSIP No. 03815U201 SCHEDULE 13G Page 4 of 6 Item 4. The shares of Common Stock reported on this Schedule are indirectly beneficially owned by the Reporting Person and directly owned by Dillon Hill Capital, LLC, of which the Reporting Person is the sole member, Dillon Hill Investment Company LLC, the investment decisions of which are controlled by the Reporting Person, and Dillon Hill Investment Company II LLC, the investment decisions of which are controlled by the Reporting Person. The Reporting Person may be deemed to have sole voting and dispositive power over the shares of Common Stock held by Dillon Hill Capital LLC and shared voting and dispositive power over the shares of Common Stock held by Dillon Hill Investment Company LLC and Dillon Hill Investment Company II LLC. (a) Amount Beneficially Owned See row 9 of cover page (b) Percent of Class See row 11 of cover page (c) Number of Shares as to which such person has (i) Sole power to vote or to direct the vote: See row 5 of cover page (ii) Shared power to vote or to direct the vote: See row 6 of cover page (iii) Sole power to dispose or to direct the disposition of: See row 7 of cover page (iv) Shared power to dispose or to direct the disposition of: See row 8 of cover page CUSIP No. 03815U201 SCHEDULE 13G Page 5 of 6 Item 5. If this statement is bein

View Full Filing

View this SC 13G/A filing on SEC EDGAR